Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?

Summary

Shares of telehealth provider Hims & Hers Health NYSE: HIMS sold off sharply following disappointing Q1 FY2026 financial results, with shares falling more than 12% in after-hours trading after the company reported on May 11. Hims & Hers Health, Inc. (HIMS) Price Chart for Tuesday, May, 12, 2026Get Hims & Hers Health alerts:Sign Up Expectations for the quarter were high, particularly after partnering with Danish multinational pharmaceutical company Novo Nordisk NYSE: NVO. In March, Novo Nordisk dismissed its patent infringement lawsuit against Hims & Hers Health and entered into a partnership with the company to sell its GLP-1 weight loss drugs Wegovy and Ozempic on the telehealth platform. But that wasn’t enough to keep the company from posting a double miss in its Q1 report, which marked the company’s fourth miss on both earnings and revenue in the past five quarters. Shares of HIMS are now down more than 50% over the past year, including a loss of nearly 20% year-to-date. The Losing Streak Continues for Hims & Hers HealthHims & Hers Health TodayHIMSHims & Hers Health$25.17 -3.97 (-13.62%) As of 01:27 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$13.74▼$70.43P/E Ratio49.52Price Target$29.37 On Monday, the company reported a Q1 earnings per share (EPS) loss of negative 40 cents, missing analyst expectations for four cents by a wide margin. Quarterly revenue came in at $608.10 million, which was also below the consensus estimate of $616.84 million. Concerningly, that figure marks just 3.8% year-over-year revenue growth. The company attributed slow revenue growth and the earnings loss to approximately $33 million in restructuring charges, including a roughly $28 million write‑down tied to the GLP‑1 compounding pivot. The earnings report wasn’t all bad news, though. Hims & Hers Health highlighted how its GLP-1 strategy pivot with Novo Nordisk is already bearing fruit. The company fulfilled more than 125,000 Wegovy shipments ...